It is probably time to be bullish as an investor. But remember two things. One: Valuations are still not cheap. Two: Because it is over and...

Longevity advocate Bryan Johnson predicts a future where humans might live indefinitely, driven by rapid advancements in biotech and AI. He...

Indian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...

As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...

Novartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

There are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...

AstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...

Precision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...

Shigella Spreading in Kerala? Kerala has intensified surveillance and testing following its first reported Shigella-related death of a four...

When mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...

At a time when there are so many headwinds for the markets, it is tough to imagine that things can get better. But sentiment is a fickle th...

For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

The latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...

After the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...

The first week of June 2026 features powerful planetary shifts influencing moods and decisions. Mercury's entry into Cancer on June 1st and...

Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...